Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Ann Vasc Surg ; 79: 122-126, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1540379


Coronavirus disease 2019 (COVID-19) has been widely reported to be associated with increased risk of Venous Thromboembolism, both deep vein thrombosis (DVT) and pulmonary embolism. A rare and extreme manifestation of DVT is Phlegmasia cerulea dolens, characterized by poor tissue perfusion due to marked limb swelling which can progress to limb and life-threatening venous gangrene. We report the case of a 53-year-old man with severe SARS-CoV2 pneumonia who developed acute iliofemoral DVT leading to acute limb ischemia due to Phlegmasia cerulea dolens. The patient underwent successful emergent fasciotomy and mechanical thrombectomy with removal of extensive thrombus burden and restoration of normal venous circulation. Our case highlights the importance of clinical vigilance and early implementation of therapeutic interventions to avoid adverse outcomes in patients who develop SARS-CoV2 induced Venous Thromboembolism complications.

COVID-19/therapy , Fasciotomy , Thrombectomy , Thrombophlebitis/surgery , Venous Thromboembolism/surgery , Anticoagulants/therapeutic use , COVID-19/complications , COVID-19/diagnosis , Humans , Male , Middle Aged , Severity of Illness Index , Thrombophlebitis/diagnosis , Thrombophlebitis/etiology , Treatment Outcome , Venous Thromboembolism/diagnosis , Venous Thromboembolism/etiology